Contraception Clinical Trial
Official title:
Bandebereho Father Groups: a Randomized Control Trial to Assess the Impact of Maternal, Newborn and Child Health Group Education for New and Expecting Fathers
Verified date | April 2017 |
Source | Promundo, United States |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study seeks to assess the impact of the MenCare+/Bandebereho fathers'/couples' group education intervention on men's attitudes towards, and participation in, sexual and reproductive health, maternal, newborn and child health, and equitable and non-violent relationships with their children and partners.
Status | Completed |
Enrollment | 2400 |
Est. completion date | January 2017 |
Est. primary completion date | January 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Men aged 21-35 years - Living with a partner - Expectant (or soon to be) father or father of young children under-5 - Living in an area with a group facilitator Exclusion Criteria: - Participated in previous cycles of the same intervention |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Promundo, United States | Rwanda Men's Resource Center (Rwamrec) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gender division of caregiving/domestic tasks (from questionnaire: a) composite capturing frequency of the respondent doing household or caregiving tasks; b) composite capturing how tasks are shared between partners). | 4 months post intervention | ||
Primary | Men's participation in family planning and maternal, newborn and child health (from questionnaire: a) men's presence at antenatal care visits; b) women's reports of receiving partner support during pregnancy; c) use of family planning). | 4 months post intervention | ||
Primary | Gender-related attitudes (from questionnaire: a continuous scale variable, adapted from the validated Gender Equitable Men (GEM) scale). | 4 months post intervention | ||
Primary | Women's experiences of intimate partner violence (from: questionnaire: a composite capturing exposure to a standard set of violent acts by a partner). | 4 months post intervention | ||
Secondary | Use of violence/harsh punishment against children (from questionnaire: a composite capturing respondents' use of various harsh discipline acts in the past month, adapted from the UNICEF MICS study). | 4 months post intervention | ||
Secondary | Relationship quality measured (from questionnaire: a) frequency of quarreling and b) quality scale adapted from the Decision Making in Low-Income Couples). | 4 months post intervention | ||
Secondary | Couple communication (from questionnaire: a composite capturing frequency of communication across multiple topics). | 4 months post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |